Department of Medicine, University of Padua, Padua, Italy.
Cytometry B Clin Cytom. 2018 Mar;94(2):334-341. doi: 10.1002/cyto.b.21507. Epub 2017 Jan 13.
BACKGROUND: Though the presence of platelets-derived microparticles (MPs) have previously been described in heparin-induced thrombocytopenia (HIT), the mechanism of thrombosis in HIT remains poorly understood. We aimed to assess the presence and origin of MPs in patients with HIT and their possible contribution to HIT with thrombosis (HITT). METHODS: Forty-five patients with HIT and 45 matched hospitalized patients with not confirmed HIT (HIT-negative) were enrolled. Twelve HIT patients (27%) developed HITT. MPs expressing phosphatidylserine (Annexin V-MP), activated platelet-derived (P-Selectin+), activated leukocyte-derived (L-Selectin+), PF4-bearing and tissue factor-bearing (TF+) MPs were measured by flow-cytometry. RESULTS: HIT patients showed significantly higher median levels of P-Selectin+, L-Selectin+, PF4-bearing, L-Selectin+/TF + MPs than HIT-negative; PF4-bearing MP showed the highest statistical difference. As compared to HIT patients, HITT patients showed a trend of higher median levels of all MP subtypes considered but the differences were not statistically significant. Only levels of activated-leukocyte/TF + MPs (L-Selectin + CD142+) were significantly higher (P = 0.015). Sensitive analyses showed that HIT patients with activated-leukocyte/TF + MPs above the cut-off (52 MP/µL) had an odds ratio (OR) for thrombosis of 3.78 (95%CI, 0.98-14.5, P = 0.045). The combination of activated-leukocyte/TF + MPs and PF4-bearing-MPs above the cut-off (1416 MP/uL) resulted in a higher risk of HITT (OR 4.49 (95% CI, 1.17-8.05, P = 0.014). CONCLUSIONS: We showed for the first time the presence of circulating PF4-bearing MPs derived from activated platelets in patients with HIT; activated leukocyte/TF + MPs are associated with an increased thrombotic risk. Our findings confirm that HIT antibodies complexes may determine a TF-driven prothrombotic state through the activation of platelets and leukocytes. © 2017 International Clinical Cytometry Society.
背景:尽管已有研究报道肝素诱导的血小板减少症(HIT)患者中存在血小板衍生的微颗粒(MPs),但 HIT 患者血栓形成的机制仍知之甚少。我们旨在评估 HIT 患者中 MPs 的存在和来源及其对 HIT 伴血栓形成(HITT)的可能贡献。
方法:纳入 45 例 HIT 患者和 45 例匹配的未确诊 HIT 的住院患者(HIT-阴性)。12 例 HIT 患者(27%)发生 HITT。采用流式细胞术检测表达磷脂酰丝氨酸(Annexin V-MP)、激活的血小板衍生(P-选择素+)、激活的白细胞衍生(L-选择素+)、PF4 结合和组织因子结合(TF+)的 MPs。
结果:HIT 患者的 P-选择素+、L-选择素+、PF4 结合、L-选择素+/TF+ MPs 的中位数水平明显高于 HIT-阴性患者;PF4 结合 MP 具有最高的统计学差异。与 HIT 患者相比,HITT 患者所有考虑的 MPs 亚型的中位数水平均呈升高趋势,但差异无统计学意义。仅激活白细胞/TF+ MPs(L-选择素+CD142+)的水平显著升高(P=0.015)。敏感分析显示,激活白细胞/TF+ MPs 水平高于临界值(52 MP/µL)的 HIT 患者发生血栓的优势比(OR)为 3.78(95%CI,0.98-14.5,P=0.045)。激活白细胞/TF+ MPs 和 PF4 结合 MPs 水平高于临界值(1416 MP/uL)的联合结果导致 HITT 的风险更高(OR 4.49(95%CI,1.17-8.05,P=0.014)。
结论:我们首次在 HIT 患者中发现循环中存在来自激活血小板的 PF4 结合 MPs;激活白细胞/TF+ MPs 与血栓形成风险增加相关。我们的研究结果证实,HIT 抗体复合物可能通过激活血小板和白细胞导致 TF 驱动的促血栓形成状态。© 2017 年国际临床细胞化学学会。
Cytometry B Clin Cytom. 2016-3-11
Front Cardiovasc Med. 2024-5-13
Int J Mol Sci. 2023-7-28
Transfus Apher Sci. 2022-6
Front Cell Dev Biol. 2022-1-17
Biomolecules. 2021-10-20
Ann Med Surg (Lond). 2022-1
Int J Mol Sci. 2021-7-26